Oncologic Safety of Laparoscopic Rectal Cancer Surgery Is Dubious
By HospiMedica International staff writers Posted on 22 Feb 2017 |
Patients undergoing laparoscopic rectal resection (LRR) have increased risk for incomplete tumor excision compared to open surgery, according to a new study.
Researchers at Henri Mondor University Hospital, Hospital Universitario Doctor Peset, and Rothschild Hospital conducted a meta-analysis of studies to examine the evidence concerning the pathologic outcomes of LRR versus open rectal resection (ORR) for rectal cancer. Of 369 records screened, 14 RCTs were selected for the qualitative and quantitative analyses. Main outcomes and measures included rate of positive circumferential resection margin (CRM) and the quality of mesorectal excision.
The researchers identified a positive CRM in 7.9% and 6.1% percent of patients undergoing LRR and ORR, respectively. In five studies, a noncomplete mesorectal excision occurred in 13.2% and 10.4% of LRR and ORR patients, respectively. There was no significant difference between LRR and ORR in the distal resection margin involvement, the mean number of lymph nodes retrieved, mean distance to the distal margin, and the mean distance to radial margins. The study was published on February 8, 2017, in JAMA Surgery.
“Based on the available evidence, the risk for achieving noncomplete mesorectal excision is significantly higher in patients undergoing LRR, compared with ORR,” concluded lead author Aleix Martínez-Pérez, MD, of Henri Mondor University Hospital, and colleagues. “These findings question the oncologic safety of laparoscopy for the treatment of rectal cancer. However, long-term results of the ongoing RCTs are awaited to assess whether these pathologic results have an effect on disease-free and overall patient survival.”
Total mesorectal excision is used in the treatment of colorectal cancer, during which a significant length of the bowel around the tumor is removed. It involves a low anterior resection for tumors of the middle and the lower rectum, wherein it is essential to remove the rectum along with the mesorectum up to the level of the levators.
Researchers at Henri Mondor University Hospital, Hospital Universitario Doctor Peset, and Rothschild Hospital conducted a meta-analysis of studies to examine the evidence concerning the pathologic outcomes of LRR versus open rectal resection (ORR) for rectal cancer. Of 369 records screened, 14 RCTs were selected for the qualitative and quantitative analyses. Main outcomes and measures included rate of positive circumferential resection margin (CRM) and the quality of mesorectal excision.
The researchers identified a positive CRM in 7.9% and 6.1% percent of patients undergoing LRR and ORR, respectively. In five studies, a noncomplete mesorectal excision occurred in 13.2% and 10.4% of LRR and ORR patients, respectively. There was no significant difference between LRR and ORR in the distal resection margin involvement, the mean number of lymph nodes retrieved, mean distance to the distal margin, and the mean distance to radial margins. The study was published on February 8, 2017, in JAMA Surgery.
“Based on the available evidence, the risk for achieving noncomplete mesorectal excision is significantly higher in patients undergoing LRR, compared with ORR,” concluded lead author Aleix Martínez-Pérez, MD, of Henri Mondor University Hospital, and colleagues. “These findings question the oncologic safety of laparoscopy for the treatment of rectal cancer. However, long-term results of the ongoing RCTs are awaited to assess whether these pathologic results have an effect on disease-free and overall patient survival.”
Total mesorectal excision is used in the treatment of colorectal cancer, during which a significant length of the bowel around the tumor is removed. It involves a low anterior resection for tumors of the middle and the lower rectum, wherein it is essential to remove the rectum along with the mesorectum up to the level of the levators.
Latest Surgical Techniques News
- Microgrippers For Miniature Biopsies to Create New Cancer Diagnostic Screening Paradigm
- Miniature Soft Lithium-Ion Battery Could Be Used as Defibrillator During Surgery
- TAVI Procedure Supported by Radial Artery Access Reduces Bleeding Complications
- Portable Surgical Robot Seamlessly Integrates into Any OR for Performing Cholecystectomy Procedures
- New Thoracic Surgery Risk Calculators Support Preoperative Decision-Making
- Surgical Platform with Miniature Humanoid-Shaped Robotic Arms Provides Human Level Dexterity
- Precision Surgical Technique Enables Lymph Node Detection and Removal in Endometrial Cancer
- Glowing Approach Helps Surgeons Assess Neural Blood Flow in Chronic Nerve Compression Neuropathy
- Predictive Model Identifies Best Patients for Minimally Invasive Epilepsy Surgery
- Light-Driven Micro-Robot Designed to Swim Autonomously in Viscous Liquids Could Be Used for Unblocking Blood Vessels
- Novel Approach Combines Advanced Robotics and Low-Field MRI Technology for Incisionless Prostate Surgery
- Fast OCT System Integrated into Neurosurgical Microscope Identifies Tumor Margins During Brain Surgery
- Miniature Robots Transport Instruments for Endoscopic Microsurgery Through Body
- Robotic Visualization System for Neurosurgery Offers Greater Clarity for Complex Procedures
- Endometrial Ablation for Abnormal Uterine Bleeding Associated with High Risk of Hysterectomy
- Breakthrough Robot Technology Could Allow Entire Surgery to Be Performed Without Human Intervention